Live Breaking News & Updates on Indian Manufacturing
Stay updated with breaking news from Indian manufacturing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
बजट 2021-22: सीआईआई ने आयात शुल्क को प्रतिस्पर्धी बनाने के लिये सुझाव दिया business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.
बजट 2021-22: सीआईआई ने आयात शुल्क को प्रतिस्पर्धी बनाने के लिये सुझाव दिया - budget 202122 cii suggested to make import duty competitive indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
New Delhi: Oxford University Press, 2019; pp xx + 295, ₹ 895. Oxford: Oxford University Press, 2019; pp xxiv + 577, price not indicated. Asia’s Journey to Prosperity: Policy, Market, and Technology Over 50 Years by Asian Development Bank, Manila: ADB, 2020 (ebook), http://dx.doi.org/10.22617/TCS190290.
The transformation of Asia from its status as the most impoverished region to the growth locomotive of the world economy within five decades is unprecedented and nothing short of a miracle. The achievement seems all the more profound when juxtaposed with a very pessimistic outlook of Asia’s development prospects made by Gunnar Myrdal in his three-volume tome Asian Drama: An Inquiry into the Poverty of Nations, published in 1968. ....
Teji Mandi: Three things investors should know on December 11, 2020 Pfizer s Covid vaccine receives thumbs up in the US: A U.S. government advisory panel has endorsed the widespread use of Pfizerâs coronavirus vaccine. According to them, the Pfizer-BioNTech vaccine appears safe and effective for adults and teenagers. The committee voted 17-4 in favor of the vaccine. With this, the Pfizer-backed vaccine is one step closer to approval for the US epic vaccination campaign. The United Kingdom (UK) has already approved the vaccine and is using it for the mass vaccination program. For India, the Pfizer vaccine appears unviable at the moment. There are storage, distribution, and cost-related issues. India is banking on CoviShield developed by the Serum Institute of India (SII). ....